Epics Therapeutics
EPICS Therapeutics is a newly created spin-off company of ULB dedicated to develop novel therapeutic solutions for cancer, based on the highly innovative field of RNA epigenetics.
€10.5M
Cumulative fund raised
“i-Tech Incubator was the initial catalyst of my encounter with Prof François Fuks, the scientific founder of Epics, as well as the go-between with experts and one of the facilitator for access to non-dilutive funding.”
Mitral Technologies
Mitral Technologies is a MedTech company developing a novel device for the treatment of functional mitral valve regurgitation through minimal invasive mitral valve repair.
€3.2M
Cumulative fund raised
“When I moved my project from the US to Belgium, I-Tech Incubator was one of my first points of contact. As a foreign company, I-Tech incubator has since been instrumental in helping me find the right people and companies to support my project. Knowledge and dedication of their team were substantial in my understanding that the move to the Walloon Region represented the most potential opportunity.”
ImmunXperts
In vitro immunology development services
€1.41M
Cumulative fund raised
“The i-Tech incubator was not only critical to succeed in our start-up phase, but continues to help us in our growth beyond our early successes”
OncoDNA
Personalized cancer treatment enabling web applications
€9M
Cumulative fund raised
“I-tech Incubator has been of great help during the early development of OncoDNA. At that time we were only 4 employees and didn't have the necessary infrastructure. I-tech Incubator was there for us”
ITEOS Therapeutics
Next generation immuno-oncology therapeutics targeting inflamed and non-inflamed tumors, spin-off from the Ludwig Cancer Research (LICR) and de Duve Institute (UCL)
€68.4M
Cumulative fund raised
“The availabilities of labs ready to use combined with external services on the biopark allowed iTeos to directly start its activities and invest into science”
TheraVet
Biotech company developing innovative treatments for high unmet medical need osteoarticular conditions (e.g., bone, joint, tendon/ligament) for small companion animals such as dogs
€1.25M
Cumulative fund raised
“The I-Tech Incubator has been a partner of choice for TheraVet : it helped identifying and introducing to VC’s and to non-dilutive funding. In addition the I-Tech Incubator was the ideal solution for TheraVet establishment in a ready-to-use infrastructure.”
Antigon
Immuno-hematology & transfusion point of care testing devices, spin-off from ULB
€3.4M
Cumulative fund raised
“Thanks to the very broad and specific network of the incubator, we managed to quickly create privileged industrial and scientific partnerships to support the development of our first medical device”
Aquilon
Aquilon Pharmaceuticals is a spin-off of ULg developing innovative inhaled formulations for the treatment of Asthma and COPD.
€7.1M
Cumulative fund raised
“i-Tech Incubator contributed to accelerate our series A fund raising journey by leveraging its scientific and clinical experts network together with its venture capital connections”
Masthercell
Cell therapy contract development and manufacturing organization
€8.4M
Cumulative fund raised
“i-Tech incubator brought major building blocks together for our project. It was the right place for us to dive into the entrepreneurial venture of developing a CDMO for the emerging cell therapy industry”
Caprion Biosciences
Caprion Biosciences, is a leading specialty clinical research organization (CRO) laboratory providing state-of-the-art integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry
“Le iTech Incubator s’est avéré un partenaire de choix lors de nos démarches en vue de notre installation en Belgique et après celle-ci, nous permettant de bien comprendre l’écosystème biotech sur le BioPark de Gosselies et nous guidant vers les divers acteurs wallons qui ont soutenu l’implantation de Caprion en Belgique.”